全文获取类型
收费全文 | 65064篇 |
免费 | 6314篇 |
国内免费 | 4330篇 |
专业分类
耳鼻咽喉 | 409篇 |
儿科学 | 1834篇 |
妇产科学 | 898篇 |
基础医学 | 13596篇 |
口腔科学 | 1362篇 |
临床医学 | 5807篇 |
内科学 | 9822篇 |
皮肤病学 | 1029篇 |
神经病学 | 4057篇 |
特种医学 | 1438篇 |
外国民族医学 | 29篇 |
外科学 | 3377篇 |
综合类 | 13141篇 |
现状与发展 | 24篇 |
一般理论 | 1篇 |
预防医学 | 3434篇 |
眼科学 | 1190篇 |
药学 | 4345篇 |
4篇 | |
中国医学 | 1511篇 |
肿瘤学 | 8400篇 |
出版年
2024年 | 61篇 |
2023年 | 1036篇 |
2022年 | 1455篇 |
2021年 | 2541篇 |
2020年 | 2395篇 |
2019年 | 2217篇 |
2018年 | 2036篇 |
2017年 | 2173篇 |
2016年 | 2374篇 |
2015年 | 2444篇 |
2014年 | 3459篇 |
2013年 | 4346篇 |
2012年 | 3415篇 |
2011年 | 4144篇 |
2010年 | 3344篇 |
2009年 | 3374篇 |
2008年 | 3653篇 |
2007年 | 3927篇 |
2006年 | 3787篇 |
2005年 | 3562篇 |
2004年 | 3216篇 |
2003年 | 2801篇 |
2002年 | 2478篇 |
2001年 | 2272篇 |
2000年 | 1889篇 |
1999年 | 1521篇 |
1998年 | 1219篇 |
1997年 | 1002篇 |
1996年 | 701篇 |
1995年 | 720篇 |
1994年 | 563篇 |
1993年 | 362篇 |
1992年 | 270篇 |
1991年 | 215篇 |
1990年 | 183篇 |
1989年 | 116篇 |
1988年 | 86篇 |
1987年 | 63篇 |
1986年 | 49篇 |
1985年 | 72篇 |
1984年 | 43篇 |
1983年 | 20篇 |
1982年 | 32篇 |
1981年 | 26篇 |
1980年 | 14篇 |
1979年 | 11篇 |
1978年 | 6篇 |
1977年 | 5篇 |
1976年 | 4篇 |
1975年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
1.
2.
Jos B. Poell Leon J. Wils Arjen Brink Ralf Dietrich Christine Krieg Eunike Velleuer Ilkay Evren Elisabeth R. Brouns Jan G. de Visscher Elisabeth Bloemena Bauke Ylstra Ruud H. Brakenhoff 《International journal of cancer. Journal international du cancer》2023,152(2):227-238
Oral squamous cell carcinomas (OSCCs) develop in genetically altered epithelium in the mucosal lining, also coined as fields, which are mostly not visible but occasionally present as white oral leukoplakia (OL) lesions. We developed a noninvasive genetic assay using next-generation sequencing (NGS) on brushed cells to detect the presence of genetically altered fields, including those that are not macroscopically visible. The assay demonstrated high accuracy in OL patients when brush samples were compared with biopsies as gold standard. In a cohort of Fanconi anemia patients, detection of mutations in prospectively collected oral brushes predicted oral cancer also when visible abnormalities were absent. We further provide insight in the molecular landscape of OL with frequent changes of TP53, FAT1 and NOTCH1. NGS analysis of noninvasively collected samples offers a highly accurate method to detect genetically altered fields in the oral cavity, and predicts development of OSCC in high-risk individuals. Noninvasive genetic screening can be employed to screen high-risk populations for cancer and precancer, map the extension of OL lesions beyond what is visible, map the oral cavity for precancerous changes even when visible abnormalities are absent, test accuracy of promising imaging modalities, monitor interventions and determine genetic progression as well as the natural history of the disease in the human patient. 相似文献
3.
4.
5.
6.
目的:探讨赣南地区原发性肺鳞癌患者EGFR和ALK基因突变的特点,科学指导此类患者优选靶向用药。方法:入组73例原发性肺鳞癌病例,采用ARMS-PNA技术检测EGFR基因第18、19、20、21外显子突变,应用不平衡法检测其中60例病例的ALK融合基因,回顾性分析EGFR和ALK基因突变患者的临床病理特征。结果:EGFR基因突变8例,阳性率为10.96%(8/73),4例为L858R突变,3例为19del突变,1例为G719X突变。女性患者突变率(66.67%,2/3)明显高于男性患者(8.57%,6/70)(P=0.030),EGFR基因突变在高龄(≥60岁)、进展期(N_(1-3)、Ⅲ+Ⅳ期)患者中相对较高,但差异无统计学意义(P>0.05)。EGFR基因突变与吸烟史、T分期以及肿瘤分布位置均无相关性(P>0.05);ALK融合基因表达2例,阳性率3.33%(2/60),与患者性别、年龄、吸烟史、TNM分期及肿瘤分布类型等各临床病理特征均无相关性(P>0.05);未发现EGFR和ALK基因共存突变病例。结论:赣南地区原发性肺鳞癌患者EGFR和ALK基因突变率相对不高,EGFR基因突变以L858R和19del突变为主,且好发于女性患者,可能是患者病情进展的预测因子之一。 相似文献
7.
8.
《中医科学杂志(英文)》2022,9(2):166-180
ObjectiveTo observe the relationship between the different stages of type 2 diabetes mellitus (T2DM) and the intestinal flora and verify its underlying mechanism.MethodsT2DM rats were generated by high-fat diet (HFD) combined with intraperitoneal streptozotocin (STZ) injection. The rats were divided into four groups: the control group (fed with normal feed for 1 month), the HFD group (fed with HFD for 1 month), the T2DM group (HFD combined with STZ and blood glucose ≥11.1 mM), and the unformed T2DM model (Un-mod) group (HFD combined with STZ and blood glucose <11.1 mM). Feces were collected, and bacterial communities in the fecal samples were analyzed by 16S rRNA gene sequencing. The content of short-chain fatty acids (SCFAs) in feces was measured by gas chromatography. Western blot and quantitative real-time polymerase chain reaction were used to detect the expression of G protein-coupled receptor 41 (GPR41) and GPR43.ResultsAt different stages of T2DM, the intestinal flora and SCFAs content of rats were significantly decreased (all P < .05). Our results indicated that g__Prevotella had a significant negative correlation, and g__Ruminococcus_torques_group and g__lachnoclastic had a significant positive correlation with blood glucose. The content of SCFAs, in particular acetate and butyrate, in rat feces of different stages of T2DM were significantly reduced, as well as GPR41 and GPR43 expression. The results in the Un-mod group were similar to the T2DM group, and the expression of GPR41 and GPR43 proteins were significantly higher than those in the T2DM group (both P < .001).ConclusionThe intestinal flora–SCFAs–GPR41/GPR43 network may be important in the development of T2DM. Decreasing blood glucose levels by regulating the intestinal flora may become a new therapeutic strategy for T2DM, which has very important clinical and social values. 相似文献
9.
《Genetics in medicine》2022,24(9):1814-1820
Although still in the early stages of development, the advent of fast, high-output, and cost-effective next-generation DNA sequencing technology is moving precision medicine into public health. Before this shift toward next-generation sequencing in public health settings, individual patients met geneticists after showing symptoms and through limited family screening. In the new era of precision public health, everyone is a possible participant in genetic sequencing, simply by being born (newborn screening), by donating blood (biobanking), or through population screening. These initiatives are increasingly offered to individuals throughout their life and more individuals are encountering opportunities to use DNA sequencing. This article raises awareness of these growing areas and calls for different models of public engagement and communication about genomics, including screening asymptomatic populations, obtaining consent for unspecified and unforeseen future uses of genomic data, and managing variants of uncertain significance. Given that such communication challenges loom large, established norms of practice in genomic medicine and research should be reconsidered. 相似文献
10.